ABCG2 and cancer: Here, we demonstrate that post-hypoxia SPm (hox)+/ABCG2+ CSCs of seven cancer cell lines including SCC-25 exhibit a TSD phenotype against BCG and Mtb-m18b that involve bystander apoptosiss and therefore could be of potential use to eliminate CSCs.